Check out your Company Bowl for anonymous work chats.
Dr Sree Ranjani, a Content Acquisition Lead at Elsevier, explains why she enjoys her role at Elsevier. "It has been a wonderful experience working with colleagues who are from different cultures and backgrounds. And personally, for me, the best part is working with researchers who are doing very fascinating and interesting research." - Dr Sree Ranjani, Content Acquisition Lead, Elsevier. As a Content Acquisition Lead at Elsevier, you have advancement opportunities in a creative environment that will help you develop as a professional and achieve an optimum career-life balance. Build your career in Publishing the way you want in a company of about 9000 employees with opportunities around the world. Work with the best minds in science and health at an organization with award-winning workplace culture. Join us. Discover Elsevier. elsevier.com/about/careers
Growing from our roots in publishing, at Elsevier, we combine quality information and vast data sets with analytics to deliver insights that help customers make critical decisions. When you work with us, your work matters. You help Researchers and Healthcare Professionals advance science, improve healthcare, and save lives. Together, we create possibilities. Discover Elsevier: https://www.elsevier.com/careers
Great colleagues, global, flexible, remote work, purposeful and rewarding career - these are some of the 10 amazing reasons to join us at Elsevier. Find out more: https://elsevier.shorthandstories.com/10-reasons-to-join-us-at-elsevier/
Happy #WomensHistoryMonth from us at Elsevier! Across Elsevier, we are proud to support initiatives that advance gender equality and women’s empowerment both within our business and in the communities where we live and work globally. Understanding the current demographic diversity of our authors, reviewers, and editors enables us to put in place actions, set goals, and measure progress in pursuit of diversity, inclusion, and equity. A gender-equal world can be healthier, wealthier, and more harmonious.
Do you know that over 7,000 rare diseases exist worldwide, and even though each one is rare individually, together they affect over 400 million people? In addition to the hundreds of millions of people who care for them, do you also know that half of all rare disease patients are children, 30% of whom will tragically die before the age of five? Rare diseases are often unknown and underappreciated because they are rare. Research on rare diseases is limited. Medical education may not provide students with the necessary information to diagnose a rare disease, and patients may be unfamiliar with the symptoms. These factors can combine to delay the diagnosis of a rare disease. When a diagnosis is made, there may be few treatment options available due to a lack of research in the area. To address this, Elsevier is marking World Rare Disease Day, February 28th, by launching the Year of the Zebra – a global initiative that will run throughout 2023.
Should medical professionals wear symbols of support for diverse populations? Wearing a supportive pin can help diverse patients feel more welcome in the clinic — but is it appropriate? A medical student explores the pros and cons. "Recently, I raised the idea of medical providers wearing an LGBTQ+ pin on their white coats as a show of support for a marginalized and discriminated group. Since I was sharing this idea online, I was prepared to receive some negative comments about my suggestion. What I wasn’t prepared for was that some of the opposing comments would make me reflect on the idea that it is OK... read more.
Great colleagues, global, flexible, remote work, purposeful and rewarding career - these are some of the 10 amazing reasons to join us at Elsevier. Find out more...
Elsevier is one of the companies offering stable career growth opportunities in 2023 according to a list compiled by Comparably, a platform that provides culture and compensation data for public and private companies. Even during unpredictable times, Elsevier remains a stable place to work because the average tenure in the organization is nearly 8 years – Elsevier is a place where people can come to build a career. By helping their employees find roles and success within Elsevier and RELX more broadly, Elsevier encourages internal mobility. The goal is to make sure that employees grow while working with the organization, regardless of how long they stay working there. The development of employees is one of the three main pillars of Elsevier's employee experience. They want their employees to be the best that they can be in their chosen careers. That’s why they believe in growth – growing skills, experience, and knowledge – every day. Comparably's article: https://www.comparably.com/blog/companies-offering-stable-career-growth-opportunities-in-2023/
We have an exciting opportunity for you to help inspire groundbreaking work by assisting researchers, clinicians, and engineers while they help tackle the biggest challenges facing humankind. Combining content, data, and analytics we help turn information into answers at Elsevier. As a global market leader, Elsevier offers a wide variety of careers and advancement opportunities in a creative environment that will help you develop as a professional and achieve an optimum career-life balance. Join us to do meaningful work. Discover Elsevier. Apply today. https://bit.ly/3CNfql1
As challenges mount for researchers in Ukraine, a professor in Kyiv talks about her experience — and how we can help Ukrainian researchers. On February 24, 2022, Nana’s life changed dramatically, along with the lives of so many people in her country, as Russian forces invaded the country. Nana recalled: "A day later, we were forced to leave Kyiv, since a part of the region was occupied. Most of our laboratory fellows moved to the Carpathian mountains in the west of Ukraine with us." Part of the reason for the move was misinformation spread by Moscow propagandists that there were secret genetic weapons in labs in Ukraine, funded by the United States. Nana and her colleagues feared that this could make them a target because their laboratory uses various genetic approaches — as is the case with most research in biomedicine today — and they have a grant from the US National Institutes of Health devoted to studies of neuro-immune interaction. Read more: https://www.elsevier.com/connect/a-researcher-tells-her-story-of-ukraines-new-reality